Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (151-160 of 539) with videos related to

Pageof 54
Sort By:
Hematological Oncology|March 16, 2013
Sorafenib in patients with refractory or recurrent multiple myelomaAnna Yordanova, Dirk Hose, Kai Neben, et al.
International Journal of Cancer|April 8, 2014
Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activityJost K Kloth, Jens Hillengass, Karin Listl, et al.
Haematologica|June 7, 2007
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell linesJérôme Moreaux, Dirk Hose, Michel Jourdan, et al.
British Journal of Haematology|March 21, 2009
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cellsCaroline Bret, Dirk Hose, Thierry Reme, et al.
Blood Cancer Journal|February 17, 2018
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcomeChunyan Gu, Carol Holman, Ramakrishna Sompallae, et al.
British Journal of Haematology|November 30, 2004
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II studyJolanta B Perz, Stefan O Schonland, Michael Hundemer, et al.
Frontiers in Oncology|May 14, 2023
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myelomaNina Rosa Neuendorff, Boryana Boshikova, Lutz Frankenstein, et al.
Journal of Clinical Apheresis|April 29, 2014
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myelomaMichael Hundemer, Melanie Engelhardt, Thomas Bruckner, et al.
Leukemia|November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myelomaMaximilian Merz, Thomas Hielscher, David Schult, et al.
Blood Cancer Journal|October 14, 2024
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myelomaAnnika Werly, Mareike Hampel, Thomas Hielscher, et al.
Pageof 54

Showing results (151-160 of 539) with videos related to

Sort By:
Pageof 54
Hematological Oncology|March 16, 2013
Sorafenib in patients with refractory or recurrent multiple myelomaAnna Yordanova, Dirk Hose, Kai Neben, et al.
International Journal of Cancer|April 8, 2014
Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activityJost K Kloth, Jens Hillengass, Karin Listl, et al.
Haematologica|June 7, 2007
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell linesJérôme Moreaux, Dirk Hose, Michel Jourdan, et al.
British Journal of Haematology|March 21, 2009
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cellsCaroline Bret, Dirk Hose, Thierry Reme, et al.
Blood Cancer Journal|February 17, 2018
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcomeChunyan Gu, Carol Holman, Ramakrishna Sompallae, et al.
British Journal of Haematology|November 30, 2004
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II studyJolanta B Perz, Stefan O Schonland, Michael Hundemer, et al.
Frontiers in Oncology|May 14, 2023
Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myelomaNina Rosa Neuendorff, Boryana Boshikova, Lutz Frankenstein, et al.
Journal of Clinical Apheresis|April 29, 2014
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myelomaMichael Hundemer, Melanie Engelhardt, Thomas Bruckner, et al.
Leukemia|November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myelomaMaximilian Merz, Thomas Hielscher, David Schult, et al.
Blood Cancer Journal|October 14, 2024
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myelomaAnnika Werly, Mareike Hampel, Thomas Hielscher, et al.
Pageof 54